Humacyte Inc Warrant
HUMAW
11 hedge funds and large institutions have $4.55M invested in Humacyte Inc Warrant in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OP
Omni Partners
London,
United Kingdom
|
+$556K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$288K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$213K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$142K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$94.5K |
Top Sellers
HUMAW Hedge Fund Activity: Q4 2020 in Review
11 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2020, worth a combined $4.55M.
Buyers outnumbered sellers: 11 funds opened new HUMAW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Omni Partners, opening a new position worth an estimated $556K.
- 11 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $4.55M of Humacyte Inc Warrant stock for Q4 2020.
- 11 funds opened new Humacyte Inc Warrant positions in Q4 2020 and 0 closed out, a net change of +11 holders.
- The largest Humacyte Inc Warrant buyer in Q4 2020 was Omni Partners, an estimated $556K added.
Based on aggregated 13F filings for Q4 2020.